Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
Bridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, Catalina Barcelo, Stephen D Woolley, Harilal Patel, Stacey Llewellyn, Azrin N Abd-Rahman, Sunil Sharma, Mukul Jain, Ashok Ghoghari, Ilaria Di Resta, Aline Fuchs, Ioanna Deni, Tomas Yeo, Sachel Mok, David A Fidock, Stephan Chalon, Jörg J Möhrle, Deven Parmar, James S McCarthy, Kevinkumar Kansagra
Topics & Concepts
MedicineVolunteerMalariaPharmacologyIntensive care medicineChloroquineHealth careDrugImmunologyInternal medicineDiseaseVivax malariaClinical trialProguanilPlasmodium falciparumPediatricsVirologyMalaria Research and ControlTuberculosis Research and EpidemiologySynthesis and biological activity